Metoprolol or Verapamil in the Management of Patients With Hypertrophic Cardiomyopathy: A Systematic Review

Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease and is a prevalent cause of sudden cardiac death (SCD). This study aims to establish the benefits and therapeutic value metoprolol or verapamil offer to patients who suffer from symptoms caused by HCM, with regard to resolvin...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Maher, Dahat, Purva, Toriola, Stacy, Satnarine, Travis, Zohara, Zareen, Adelekun, Ademiniyi, Seffah, Kofi D, Salib, Korlos, Dardari, Lana, Arcia Franchini, Ana P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411313/
https://www.ncbi.nlm.nih.gov/pubmed/37565181
http://dx.doi.org/10.7759/cureus.43197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411313/
https://www.ncbi.nlm.nih.gov/pubmed/37565181
http://dx.doi.org/10.7759/cureus.43197

Ejemplares similares